Correvio Pharma Corp CORV.TO :
* CORREVIO ANNOUNCES CHIEF EXECUTIVE OFFICER SUCCESSION PLAN AND OTHER BOARD AND EXECUTIVE CHANGES
* CORREVIO PHARMA CORP - CHIEF FINANCIAL OFFICER, JUSTIN RENZ, APPOINTED PRESIDENT
* CORREVIO PHARMA CORP - VANDA DE CIAN, MD, TO JOIN BOARD OF DIRECTORS
* CORREVIO PHARMA CORP - HUNTER TO REMAIN A MEMBER OF BOARD OF DIRECTORS
* CORREVIO PHARMA CORP - MARK H.N. CORRIGAN, MD TO SUCCEED WILLIAM HUNTER, MD AS CHIEF EXECUTIVE OFFICER BY END OF Q1 2019
* CORREVIO PHARMA CORP - DE CIAN WILL SERVE AS A MEMBER OF NOMINATING, GOVERNANCE AND COMPENSATION COMMITTEES
* CORREVIO PHARMA CORP - HUNTER WILL TRANSITION OUT OF HIS CURRENT ROLE BY END OF Q1 OF 2019